MUP is one of the most recent pharmaceutical firms in Egypt. In the scenic region near the city of Ismailia, MUPhas established a modern pharmaceutical manufacturing facility which incorporates many contemporary construction design features, raw materials handling, production concepts, and state-of-the-art manufacturing lines which rival the most modern American, European and Japanese counterparts. MUP adopts the Total Quality Management (TOM) concept and methodology in all departments and up-to-date Quality Assurance (QA) techniques, not only in all production processes, but also in all administrative and supporting departments.
MUP acquired the latest ISO 9001:2008 Certificate from the British Standards Institute (bsi), and recently upgraded the conventional plant to be certified to ISO, 14001, 18001 & 17025 by the end of year 2015 . MUP is proceeding in the new Cephalosporin and Penicillin Plants and all sets for the EMEA certification.
Today, MUP provides trusted generic, branded generic and specialty pharmaceutical products to more than 30 countries in Africa, the MENA region, and Western Europe and are aggressively building a leading position in providing international initiatives satisfying countries and communities that collaborate with us. MUP provides many products that cover several therapeutic areas, such as:
Gastroenterology, Dermatology, Gynecology, Andrology, Cardiovascular, Dentistry, Anti-Infectives, Vitamins and Tonics, Anti-Histaminics, Analgesics and Anti-Rheumatics, Endocrinology, Hepatology, Respiratory, Neurology.
Contact
Headquarters
MUP, Inc. 36 Dr . Mohammad Hassan El-Gamal St., 6th District-Nasr City- Cairo-A.R.E P.O.Box : 7010 Nasr City Kost No : 11768 Tel : (+20) 22709324 / 22709316 / 22709535 / 22726169 Fax : (+20) 22709315
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence…
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
On Tuesday, February 12th, Pharmaboardroom attended a breakfast event hosted by the British Egyptian Business Association (BEBA) on competition law at the Cairo Semiramis Intercontinental Hotel. The theme for the…
Tarek Tawfik, managing director of AmCham Egypt, explains how Egypt’s latest economic reforms have transformed the country into an attractive destination for foreign investors. He highlights the special role of…
Nadia Lamloum, executive director of the British Egyptian Business Association (BEBA), discusses the role of her institution and the investment opportunities that Egypt has to offer, as well as the…
Dr Magdy Abdelhamid, president of the Egyptian Society of Cardiology, explains the main trends in cardiology in Egypt and the society’s prevention projects. He also gives insights into the latest…
Hassan Behnam, managing director of the French Chamber of Commerce and Industry in Egypt explains the investment opportunities Egypt has to offer, examines the close relationship between Egypt and France…
Last week saw the first meeting of the board of Egypt’s new Universal Healthcare Authority (UHA) managed by the Minister of Finance, Mohamed Maait. Created to oversee the implementation of…
Egypt continues to struggle with fake drugs reaching the hands of patients as the suppliers of counterfeit medicines become more sophisticated by adding company logos to packaging. The Egyptian police…
The Health Committee of the Egyptian House of Representatives is preparing to discuss a draft law from the government on the establishment of the “Egyptian Drug Authority.” The new…
Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and…
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease…
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis…